Holen Sie sich die Stockscreener-App
1.22
2.08%
0.02
Handel nachbörslich:
1.21
-0.01
-0.82%
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
Neuronetics Analyst Ratings and Price Targets | NASDAQ:STIM - Benzinga
Neuronetics Inc (STIM) Stock Price, Quote, News & History - Benzinga
Neuronetics, Inc. Signs $26,000/Month Consulting Agreement with Francis X. Brown III – 8-K Filing Details and Agreement Terms - Minichart
Neuronetics updates consulting agreement for interim financial officer - Investing.com
Neuronetics updates consulting agreement for interim financial officer By Investing.com - Investing.com UK
Neuronetics (NASDAQ: STIM) sets new monthly pay for interim finance chief - Stock Titan
Neuronetics, Inc. Appoints Francis X. Brown III as Accounting Officer, Effective as of May 5, 2026 - marketscreener.com
STIM Stock Price, Quote & Chart | NEURONETICS INC (NASDAQ:STIM) - ChartMill
Neuronetics (STIM) ex-CFO corrects insider sale to 8,569 tax-withheld shares - Stock Titan
STIM PE Ratio & Valuation, Is STIM Overvalued - Intellectia AI
STIM SEC FilingsNeuronetics 10-K, 10-Q, 8-K Forms - Stock Titan
Insider Buying: Jorey Chernett Acquires 100,000 Shares of Neuron - GuruFocus
Neuronetics 10% owner Chernett buys $117,000 in common stock - Investing.com UK
Neuronetics 10% owner Chernett buys $117,000 in common stock By Investing.com - Investing.com Australia
Neuronetics (NASDAQ: STIM) large holder buys 100,000 shares - Stock Titan
Neuronetics(STIM) Stock Options Chain | Quotes & News - Moomoo
Neuronetics stock (US63009R1005): earnings move puts focus back on growth outlook - AD HOC NEWS
Neuronetics Revenue Rises as Clinic Business Expands - MyChesCo
Neuronetics partners with ANT Neuro on neuronavigation tech By Investing.com - Investing.com South Africa
Neuronetics and Ant Neuro announce strategic collaboration to integrate neuronavigation with Neurostar TMS treatment - marketscreener.com
Neuronetics partners with ANT Neuro on neuronavigation tech - Investing.com India
Neuronetics And Ant Neuro Announce Strategic Collaboration To Integrate Neuronavigation With Neurostar Tms Treatment - TradingView
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment - The Manila Times
Neuronetics (STIM) interim PAO reports 19,968 Common Stock shares - Stock Titan
Insider Buying: Jorey Chernett Acquires 475,000 Shares of Neuron - GuruFocus
Neuronetics: Jorey Chernett buys $636,500 in shares By Investing.com - Investing.com India
Neuronetics: Jorey Chernett buys $636,500 in shares - Investing.com UK
Neuronetics Insider Bought Shares Worth $636,500, According to a Recent SEC Filing - marketscreener.com
Neuronetics 10% Owner Purchased Shares Worth Over $636K - TradingView
Neuronetics | 4: Statement of changes in beneficial ownership of securities-10% Owner Chernett Jorey - Moomoo
Large Neuronetics (STIM) shareholder adds 475,000 shares in open-market buy - Stock Titan
Neuronetics stock (US63009R1005): Innovative Neurostimulation Leader - AD HOC NEWS
MSN Money - MSN
Neuronetics (STIM) Q1 2026 Earnings Transcript - AOL.com
Neuronetics outlines $160M-$166M 2026 revenue outlook with focus on $2.5M-$3M annualized cost savings - MSN
Full Transcript: Neuronetics Q1 2026 Earnings Call - Sahm
Neuronetics, Inc. (NASDAQ:STIM) Q1 2026 Earnings Call Transcript - Insider Monkey
Neuronetics Q1 2026 slides: revenue rises 8% amid profitability push By Investing.com - Investing.com Australia
Geopolitical Turmoil and Supply Chain Strains Threaten Neuronetics’ Costs, Margins, and Growth - TipRanks
1.35%
2.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):